A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...
A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...
Orca Bio, a commercial-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the U.S. Food and Drug Administration (FDA) has ...
A new study from Ben-Gurion University of the Negev (BGU) has revealed that long-term Salmonella infections severely damage blood stem cells—the essential factory cells in bone marrow that produce all ...
Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these ...
T-cells are the immune system's frontline defenders with a crucial role in controlling HIV. In a milestone clinical trial ...
A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as ...
Suma Prakash had never smoked a day in her life. A 54-year-old schoolteacher from Kochi, she had breathed the city’s ...
As Nigeria joined the rest of the world to commemorate World Sickle Cell Day, stakeholders have raised concern over the high ...
(Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy ® (sacituzumab govitecan-hziy), a first-in-class Trop-2-directed antibody-drug conjugate (ADC), ...
Gene therapy has given sickle cell disease what medicine has long promised but rarely delivered: the possibility of a cure. Yet the slow uptake of Casgevy and Lyfgenia shows that even dazzling science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results